Acticor Biotech’s IPO

McDermott has advised Acticor Biotech on the offering. Acticor Biotech, a clinical stage biopharmaceutical company dedicated to developing a drug for the treatment of cardiovascular emergencies,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Luxempart’s Investment in Evariste

Fieldfisher advised Luxempart on the deal. UGGC Avocats advised Evariste. Luxempart, an investment company listed on the Luxembourg Stock Exchange, acquired a significant stake in Evariste,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here